Literature DB >> 84896

Recommended site and depth of newborn heel skin punctures based on anatomical measurements and histopathology.

T A Blumenfeld, G K Turi, W A Blanc.   

Abstract

The heels of 40 children (0.56--13.15 kg), 35 of whom were newborn infants and 28 of whom had 2--20 visible skin punctures, were examined at necropsy, and the thickness of the tissue layers was measured with a metric vernier caliper. Histological examination showed that uncomplicated skin-puncture wounds heal with minimum scarring and no neuroma formation. 1 infant had an infected puncture track extending into the calcaneus and resulting in cellulitis and focal calcaneal necrotising chondritis. The skin's primary blood-supply is located at the junction of the dermis and subcutaneous tissue, and the distance from the surface of the heel to this junction was quite constant (0.35--1.6 mm). However, the distance from the skin surface to the calcaneus increased with infant weight (in the smallest infant it was 2.4 mm), and at the posterior curvature of the heel it was half that from the plantar surface to the calcaneus. The calcaneus rarely extended lateral to a line drawn posteriorly from a point midway between the 4th and 5th toes and running parallel to the lateral aspect of the heel or medial to a line extending posteriorly from the middle of the great toe and running parallel to the medial surface of the heel. Therefore, in order to avoid calcaneal puncture and the risk of osteochondritis, heel puncture in the newborn should be done: (1) on the most medial or lateral portions of the plantar surface of the heel; (2) no deeper than 2.4 mm; (3) not on the posterior curvature of the heel; and (4) not through previous puncture sites that may be infected.

Entities:  

Mesh:

Year:  1979        PMID: 84896     DOI: 10.1016/s0140-6736(79)90765-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  10 in total

1.  Ultrasound study of heel to calcaneum depth in neonates.

Authors:  A Jain; N Rutter
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-05       Impact factor: 5.747

2.  Osteomyelitis of the calcaneus in the newborn: an ongoing complication of Guthrie test.

Authors:  Selçuk Yüksel; Gülten Yüksel; Selim Oncel; Elfi Divanli
Journal:  Eur J Pediatr       Date:  2006-11-03       Impact factor: 3.183

3.  Capillary blood sampling: should the heel be warmed?

Authors:  D P Barker; B Willetts; V C Cappendijk; N Rutter
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-03       Impact factor: 5.747

4.  Scarring of the hands resulting from venipunctures in babies.

Authors:  A L Den Ouden; H M Berger; J H Ruys
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

5.  Heel blood sampling in preterm infants: which technique?

Authors:  D P Barker; B W Latty; N Rutter
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-11       Impact factor: 5.747

6.  Making heel pricks less painful.

Authors:  V A Harpin; N Rutter
Journal:  Arch Dis Child       Date:  1983-03       Impact factor: 3.791

7.  An automatic incision device for obtaining blood samples from the heels of preterm infants causes less damage than a conventional manual lancet.

Authors:  H Vertanen; V Fellman; M Brommels; L Viinikka
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-01       Impact factor: 5.747

8.  Skin to calcaneus distance in the neonate.

Authors:  J Arena; J I Emparanza; A Nogués; A Burls
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-05-04       Impact factor: 5.747

Review 9.  The evaluation and management of pain in the infant and young child with cancer.

Authors:  D Berman; A M Duncan; L K Zeltzer
Journal:  Br J Cancer Suppl       Date:  1992-08

Review 10.  Capillary blood sampling: national recommendations on behalf of the Croatian Society of Medical Biochemistry and Laboratory Medicine.

Authors:  Jasna Lenicek Krleza; Adrijana Dorotic; Ana Grzunov; Miljenka Maradin
Journal:  Biochem Med (Zagreb)       Date:  2015-10-15       Impact factor: 2.313

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.